Organon & Co. Common Stock (NY:OGN)

13.51 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jul 21, 2026 Add to My Watchlist

Price and Volume

Volume	16
Open	13.51
Bid (Size)	13.50 (9,900)
Ask (Size)	13.55 (900)
Prev. Close	13.51
Today's Range	13.51 - 13.51
52wk Range	5.690 - 13.60
Shares Outstanding	259,965,579
Dividend Yield	0.59%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing

July 16, 2026

From Organon & Co.

Via Business Wire

Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting

July 07, 2026

From Organon & Co.

Via Business Wire

Performance

YTD	+86.6%	+86.6%
1 Month	+0.8%	+0.8%
3 Month	+52.8%	+52.8%
6 Month	+42.8%	+42.8%
1 Year	+43.0%	+43.0%

More News

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

June 24, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

June 22, 2026

From Organon & Co.

Via Business Wire

Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders

June 16, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)

June 16, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

June 10, 2026

From Organon & Co.

Via Business Wire

Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders

June 09, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)

June 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Organon to Present New Research on Access and Value at ISPOR 2026

May 15, 2026

From Organon & Co.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX)

May 14, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders

May 06, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SLNO, OGN, RMAX, XOMA are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether MKC, LEG, OGN, KW are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

May 05, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether AVNS, OGN, ESQ, VRE are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates

April 30, 2026

Via StockStory

Organon Reports Results for the First Quarter Ended March 31, 2026

April 30, 2026

From Organon & Co.

Via Business Wire

Organon Cancels First Quarter Earnings Call

April 29, 2026

From Organon & Co.

Via Business Wire

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

April 28, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders

April 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal ↗

April 27, 2026

Via The Motley Fool

Monday's session: most active stocks ↗

April 27, 2026

Via Chartmill

April 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Frequently Asked Questions

Is Organon & Co. Common Stock publicly traded?

Yes, Organon & Co. Common Stock is publicly traded.

What exchange does Organon & Co. Common Stock trade on?

Organon & Co. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Organon & Co. Common Stock?

The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange

What is the current price of Organon & Co. Common Stock?

The current price of Organon & Co. Common Stock is 13.51

When was Organon & Co. Common Stock last traded?

The last trade of Organon & Co. Common Stock was at 07/21/26 07:00 PM ET

What is the market capitalization of Organon & Co. Common Stock?

The market capitalization of Organon & Co. Common Stock is 3.51B

How many shares of Organon & Co. Common Stock are outstanding?

Organon & Co. Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.